Dynavax Technologies (DVAX) Stock Price, Quote & News

Company Profile

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also develops rF1V, a plague vaccine candidate in Phase 2 clinical trial; and Z-1018, an investigational vaccin...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 510 848 5100

Fax: 510 848 1327

Website: www.dynavax.com

Address:

2100 Powell Street, Suite 720, EmeryVille, United States

VictorJung Aug. 6 at 8:04 PM

$DVAX someone on the call tomorrow press Spencer on the hemodialysis trial Oh and how exactly is this a ”transformational year” oh and why you poached a global launch expert from Merck 3 years back and have zero plans on a global launch, oh and why you have a poison pill in place when GS sold half their stake and……theres just too much!!!!

0 · Reply

KWalzz Aug. 6 at 4:59 PM

$DVAX from IBKR, 0.10 EPS (consensus). last ER was 0.03 consensus EPS and -0.11 actual, was a significant miss. This time even higher SG&A ? even lower sales growth ? or surprise ? (I'd prefer one).

0 · Reply

martycar97 Aug. 6 at 11:40 AM

$DVAX https://apnews.com/article/kennedy-vaccines-mrna-pfizer-moderna-1fb5b9436f2957075064c18a6cbbe3c9#

1 · Reply

KWalzz Aug. 6 at 11:40 AM

$DVAX sold all my BBIO shares (30k) yesterday for 49.26, my avg was ~ 30. Brought the profit that I could have made here in 21s in 2021 back then. While I was pretty sure that BBIO will go down on a miss (which it had re eps) I am still not sure what tomorrow will bring here for DVAX. I am tempted to sell half of my holdings here after the profit I made with BBIO. If DVAX fails tomorrow regarding EPS like it did with last ER we could see a massive drop here, too, which I would not want to see. What is your take for tomorrow's ER? Will they finally deliver profitability or an eps fail?

0 · Reply

KWalzz Aug. 4 at 3:28 PM

$DVAX let's hope we do not face a move down like TGTX today (-18%) on thursday in case we also miss eps for a second time ...

0 · Reply

KWalzz Aug. 4 at 2:35 PM

$DVAX is about how low can it go .... how low can volume go ? how low can share price go ? how low can interest in this go ? how low can everything else go here ? how low can Myers & Spencer fall ? low, lower, Dynalow ....

0 · Reply

Estimize Aug. 4 at 1:09 PM

Wall St is expecting 0.14 EPS for $DVAX Q3 [Reporting 10/30 AMC] http://www.estimize.com/intro/dvax?chart=historical&metric_name=eps&utm_co

0 · Reply

KWalzz Aug. 1 at 6:04 PM

$DVAX waiting for years now ...

0 · Reply

Dvax2theMoon Aug. 1 at 3:32 PM

$DVAX of course they will drive it down before ER

2 · Reply

KWalzz Aug. 1 at 10:44 AM

$DVAX Goldman Sachs reported back in June that they sold 53% of their Dynaloser holdings ... went a bit under the radar.

3 · Reply

Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

Jun 11, 2025, 12:14 PM EDT - 2 months ago

Dynavax elects all four of its nominees after Deep Track proxy fight

Jun 11, 2025, 11:01 AM EDT - 2 months ago

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

Jun 9, 2025, 8:30 AM EDT - 2 months ago

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

Jun 9, 2025, 7:30 AM EDT - 2 months ago

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

Jun 4, 2025, 4:59 PM EDT - 2 months ago

Dynavax Comments on Glass Lewis Recommendation

Jun 4, 2025, 9:27 AM EDT - 2 months ago

Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies

May 28, 2025, 4:10 PM EDT - 2 months ago

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

May 23, 2025, 6:12 PM EDT - 2 months ago

Deep Track Capital Comments on ISS Recommendation

May 23, 2025, 1:54 PM EDT - 2 months ago

ISS backs Dynavax directors in board fight with Deep Track Capital

May 23, 2025, 1:44 PM EDT - 2 months ago

Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees

May 21, 2025, 11:48 PM EDT - 2 months ago

Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good

May 15, 2025, 4:00 PM EDT - 2 months ago

Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting

May 12, 2025, 7:30 AM EDT - 3 months ago

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value

May 7, 2025, 4:45 PM EDT - 3 months ago

Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum

May 6, 2025, 7:34 PM EDT - 3 months ago

Dynavax Technologies Corporation (DVAX) Q1 2025 Earnings Call Transcript

May 6, 2025, 4:01 PM EDT - 3 months ago

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs

May 6, 2025, 8:00 AM EDT - 3 months ago

Deep Track Capital Releases Investor Presentation on Dynavax Technologies

May 1, 2025, 8:00 AM EDT - 3 months ago

Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits

Apr 29, 2025, 7:30 AM EDT - 3 months ago

Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy

Apr 22, 2025, 4:00 PM EDT - 3 months ago

Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

Apr 21, 2025, 4:05 PM EDT - 3 months ago

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Apr 17, 2025, 7:15 AM EDT - 3 months ago

Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders

Apr 16, 2025, 8:00 AM EDT - 4 months ago

Deep Track Capital Comments on Dynavax Technologies' Rejection of Most Recent Settlement Offer

Apr 3, 2025, 5:40 PM EDT - 4 months ago

Dynavax Files Preliminary Proxy Statement

Mar 10, 2025, 8:00 AM EDT - 5 months ago

Deep Track Capital Sends Letter to Dynavax Technologies' Board of Directors

Mar 6, 2025, 6:00 AM EST - 5 months ago

Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase

Mar 3, 2025, 5:58 PM EST - 5 months ago

Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share

Feb 25, 2025, 4:10 PM EST - 5 months ago

Dynavax to Participate in Upcoming Investor Conferences

Feb 20, 2025, 6:38 PM EST - 5 months ago

Dynavax Technologies Corporation (DVAX) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 4:01 PM EST - 5 months ago

Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance

Feb 19, 2025, 4:52 PM EST - 6 months ago

Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy

Feb 19, 2025, 9:00 AM EST - 6 months ago

Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies' Board of Directors at 2025 Annual Meeting

Feb 19, 2025, 8:04 AM EST - 6 months ago

Exclusive: Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors

Feb 11, 2025, 3:11 PM EST - 6 months ago

Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty

Feb 6, 2025, 5:42 PM EST - 6 months ago

Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025

Jan 27, 2025, 6:00 AM EST - 6 months ago

Dynavax Advances Board Refreshment Program

Jan 13, 2025, 9:00 AM EST - 7 months ago

Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights

Nov 26, 2024, 4:05 PM EST - 9 months ago

Dynavax to Present at the 7th Annual Evercore HealthCONx Conference

Nov 13, 2024, 6:36 PM EST - 9 months ago

Dynavax Technologies: What The Stock Buyback Means. What It Doesn't

Nov 11, 2024, 8:00 AM EST - 9 months ago

Dynavax Announces $100 Million Accelerated Share Repurchase Program

Nov 7, 2024, 7:46 PM EST - 9 months ago

Dynavax Technologies Corporation (DVAX) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:02 PM EST - 9 months ago

Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates

Nov 7, 2024, 4:01 PM EST - 9 months ago

Dynavax Announces $200 Million Share Repurchase Program

Nov 6, 2024, 1:10 PM EST - 9 months ago

Glancy Prongay & Murray LLP Announces Investigation of Dynavax Technologies Corporation (DVAX)

Oct 29, 2024, 8:30 AM EDT - 10 months ago

Dynavax Adopts Limited-Duration Stockholder Rights Plan

Oct 24, 2024, 4:10 PM EDT - 10 months ago

Dynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024

Sep 25, 2024, 12:46 PM EDT - 11 months ago

3 'Repeatable' Biotech Trades

FOLD GSK NTLA XBI

Aug 23, 2024, 4:32 AM EDT - 1 year ago

Dynavax Technologies: A Two Trick Pony Operating With A Single Trick

Aug 6, 2024, 8:54 PM EDT - 1 year ago

Dynavax Technologies Corporation (DVAX) Q2 2024 Earnings Call Transcript

VictorJung Aug. 6 at 8:04 PM

0 · Reply

KWalzz Aug. 6 at 4:59 PM

$DVAX from IBKR, 0.10 EPS (consensus). last ER was 0.03 consensus EPS and -0.11 actual, was a significant miss. This time even higher SG&A ? even lower sales growth ? or surprise ? (I'd prefer one).

0 · Reply

martycar97 Aug. 6 at 11:40 AM

$DVAX https://apnews.com/article/kennedy-vaccines-mrna-pfizer-moderna-1fb5b9436f2957075064c18a6cbbe3c9#

1 · Reply

KWalzz Aug. 6 at 11:40 AM

0 · Reply

KWalzz Aug. 4 at 3:28 PM

$DVAX let's hope we do not face a move down like TGTX today (-18%) on thursday in case we also miss eps for a second time ...

0 · Reply

KWalzz Aug. 4 at 2:35 PM

0 · Reply

Estimize Aug. 4 at 1:09 PM

Wall St is expecting 0.14 EPS for $DVAX Q3 [Reporting 10/30 AMC] http://www.estimize.com/intro/dvax?chart=historical&metric_name=eps&utm_co

0 · Reply

KWalzz Aug. 1 at 6:04 PM

$DVAX waiting for years now ...

0 · Reply

Dvax2theMoon Aug. 1 at 3:32 PM

$DVAX of course they will drive it down before ER

2 · Reply

KWalzz Aug. 1 at 10:44 AM

$DVAX Goldman Sachs reported back in June that they sold 53% of their Dynaloser holdings ... went a bit under the radar.

3 · Reply

KWalzz Aug. 1 at 6:18 AM

$DVAX what about HEPLISAV SALES GROWTH ? we will see August, 7. this what counts only atm.

0 · Reply

KWalzz Aug. 1 at 6:08 AM

$DVAX "there seems to be" something with somehing here ...

0 · Reply

KWalzz Aug. 1 at 6:03 AM

$DVAX pumpy schemes ...

0 · Reply

AccuRoger Aug. 1 at 12:05 AM

$DVAX This Human Heplisav USA trial for Chronic HepB was just posted. Add this to the TherVacB study out of Germany that started enrolling subjects. There seems to be a pattern of researcher interest and Management SILENCE. Fundamental Analysis is harder when Management kowtows to Goldman Sachs and the bond holders over Retail Investors. See the recent unnecessary extension of Debt as an example. https://clinicaltrials.gov/study/NCT04843852

2 · Reply

VictorJung Jul. 31 at 11:25 PM

$DVAX in this forever and ive made 28%. Opportunity cost is killing me.

4 · Reply

KWalzz Jul. 31 at 3:50 PM

$DVAX short interest was updated (see nasdaq), now for the 5th time in a row ~ 15m shares short, not that this is of interest, it is Dynashit or Dynashort?

1 · Reply

Gv32832 Jul. 31 at 3:20 PM

$DVAX pos this stock is held by an institutional investor who shorts it at will to make money

1 · Reply

Noobnr1 Jul. 31 at 8:19 AM

$PHAR 🚀 Very nice and rising results 🚀 $PFE $DVAX $GILD 💎💎💎

0 · Reply

KWalzz Jul. 31 at 5:21 AM

$DVAX according to lazy Spencer the ER is Aug, 7. https://investors.dynavax.com/news-releases/news-release-details/dynavax-report-second-quarter-2025-financial-results-and-host

0 · Reply

KWalzz Jul. 30 at 8:06 PM

$DVAX received from IBKR, says tomorrow is DVAX ER .. let's see ...

1 · Reply

chrlaff01 Jul. 30 at 2:03 PM

$DVAX

0 · Reply

Dvax2theMoon Jul. 29 at 2:33 PM

$DVAX dull and boring… sad

3 · Reply

Market Cap	1.34B
Revenue (ttm)	277.25M
Net Income (ttm)	27.31M
EPS (ttm)	N/A
PE Ratio	79.57
Forward PE	N/A
Profit Margin	9.85%
Debt to Equity Ratio	0.00

Volume	885,000
Avg Vol	1,572,882
Day's Range	N/A - N/A
Shares Out	120.08M
Stochastic %K	59%
Beta	1.09
Analysts	Sell
Price Target	$22.00